3,4-Methylenedioxy-N-methoxyamphetamine
3,4-Methylenedioxy-N-methoxyamphetamine[edit]
3,4-Methylenedioxy-N-methoxyamphetamine (MDMEO) is a psychedelic and empathogen of the amphetamine class. It is structurally related to MDMA (3,4-methylenedioxy-N-methylamphetamine) and is known for its psychoactive effects.
Chemical Structure[edit]
MDMEO is a derivative of amphetamine and is characterized by the presence of a methylenedioxy group attached to the phenyl ring and a methoxy group attached to the nitrogen atom. This structure is similar to that of MDMA, with the primary difference being the substitution of a methoxy group for the methyl group on the nitrogen.
Pharmacology[edit]
MDMEO acts primarily as a serotonin releasing agent, similar to other compounds in the MDxx family. It increases the levels of serotonin in the synaptic cleft by promoting the release of serotonin from neurons. This action is responsible for its mood-enhancing and empathogenic effects.
Effects[edit]
The effects of MDMEO are similar to those of MDMA, including increased empathy, euphoria, and altered sensory perception. Users may experience enhanced emotional connectivity and a sense of well-being. However, the specific effects can vary depending on the dose and individual sensitivity.
Legal Status[edit]
The legal status of MDMEO varies by country. In many jurisdictions, it is classified as a controlled substance due to its structural similarity to MDMA and its potential for abuse.
Related Compounds[edit]
MDMEO is part of a larger family of substituted amphetamines, which includes:
Related Pages[edit]
| Phenethylamines | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
